| DRD2 |
DRD2: D(2) dopamine receptor |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.848 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.848 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.848 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.848 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.848 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.848 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.848 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.848 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.848 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
LOC643930 |
CCL3L1, D17S1718, G0S19-2, SCYA3L1: Small-inducible cytokine A3-like 1 precursor |
0.848 |
Evidence |
|
| EDN3 |
EDN3: Endothelin-3 precursor |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
0.848 |
Evidence |
|
| OSM |
OSM: Oncostatin-M precursor |
LEPR |
LEPR, DB, OBR: Leptin receptor precursor |
0.848 |
Evidence |
|
| OSM |
OSM: Oncostatin-M precursor |
IL6ST |
IL6ST: Interleukin-6 receptor subunit beta precursor |
0.848 |
Evidence |
|
| ICAM2 |
ICAM2: Intercellular adhesion molecule 2 precursor |
NF2 |
NF2, SCH: Merlin |
0.848 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
0.848 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
0.848 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
0.848 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
0.848 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
0.848 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
DRD2 |
DRD2: D(2) dopamine receptor |
0.848 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
0.848 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
0.848 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
0.848 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
0.848 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
0.848 |
Evidence |
|